These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1650417)

  • 1. Re-evaluation of the effects of neuropeptide Y on aggregation of human platelets.
    Myers AK; Abi-Younes S; Zukowska-Grojec Z
    Life Sci; 1991; 49(7):545-51. PubMed ID: 1650417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet neuropeptide Y and its vasoconstriction effect in rat].
    Yang YF; Yang LH; Shi GP; Han QD
    Sheng Li Xue Bao; 1993 Aug; 45(4):400-4. PubMed ID: 8296217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y and platelet aggregation by adrenaline.
    Dewar HA; Zar MA; Oxley A
    Life Sci; 1989; 45(5):367-70. PubMed ID: 2770405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet neuropeptide Y in spontaneously hypertensive rats.
    Ogawa T; Kitamura K; Kangawa K; Matsuo H; Eto T
    J Hypertens; 1992 Aug; 10(8):765-71. PubMed ID: 1325508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of release of neuropeptide Y in vitro from platelets of spontaneously hypertensive rats.
    Chen SH; Han QD
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):149-52. PubMed ID: 7597917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of immunoreactive-neuropeptide by rat platelets.
    Myers AK; Farhat MY; Vaz CA; Keiser HR; Zukowska-Grojec Z
    Biochem Biophys Res Commun; 1988 Aug; 155(1):118-22. PubMed ID: 3415675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of epinephrine-induced platelet aggregation.
    Spalding A; Vaitkevicius H; Dill S; MacKenzie S; Schmaier A; Lockette W
    Hypertension; 1998 Feb; 31(2):603-7. PubMed ID: 9461228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
    Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
    Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet monoamine oxidase and epinephrine-induced platelet aggregation.
    Rossi EC; Louis G; Bieber M; Zeller EA
    Thromb Haemost; 1978 Aug; 40(1):37-42. PubMed ID: 725849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
    Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive neuropeptide Y (NPY) in plasma and platelets of rat and mouse strains and human volunteers.
    Myers AK; Torres Duarte AP; Zukowska-Grojec Z
    Regul Pept; 1993 Sep; 47(3):239-45. PubMed ID: 8234908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
    Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
    Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.